心脏外科围手术期连续性肾脏替代治疗专家共识

2019-01-29 中国胸心外科相关专家组(统称) 中华医学杂志.2019.99(5):321-328..

中国心脏重症CRRT专家共识工作组基于循证医学证据及临床经验制定心脏外科围手术期CRRT应用专家共识。

中文标题:

心脏外科围手术期连续性肾脏替代治疗专家共识

发布日期:

2019-01-29

简要介绍:

中国心脏重症CRRT专家共识工作组基于循证医学证据及临床经验制定心脏外科围手术期CRRT应用专家共识。 

拓展指南:围手术期相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=心脏外科围手术期连续性肾脏替代治疗专家共识)] GetToolGuiderByIdResponse(projectId=1, id=7f0721c001e32838, title=心脏外科围手术期连续性肾脏替代治疗专家共识, enTitle=, guiderFrom=中华医学杂志.2019.99(5):321-328.., authorId=null, author=, summary=中国心脏重症CRRT专家共识工作组基于循证医学证据及临床经验制定心脏外科围手术期CRRT应用专家共识。 , cover=, journalId=null, articlesId=null, associationId=1269, associationName=中国胸心外科相关专家组(统称), associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 29 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>中国心脏重症CRRT专家共识工作组基于循证医学证据及临床经验制定心脏外科围手术期CRRT应用专家共识。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>围手术期</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=fcd541c001e281bc" title="围手术期血压管理医-药专家共识" target=_blank>围手术期血压管理医-药专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=2ad6c1c001e275f3" title="2019 SPA建议:儿童围手术期阿片类药物的应用" target=_blank>2019 SPA建议:儿童围手术期阿片类药物的应用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=77cb31c001e1869f" title="成年人非阿片类镇痛药围手术期应用专家共识" target=_blank>成年人非阿片类镇痛药围手术期应用专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=cd3001c00168e23f" title="颈椎病的手术治疗及围手术期管理专家共识(2018)" target=_blank>颈椎病的手术治疗及围手术期管理专家共识(2018)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=1c2cb1c0016e73df" title="甲状腺围手术期甲状旁腺功能保护指南(2018版)" target=_blank>甲状腺围手术期甲状旁腺功能保护指南(2018版)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%9B%B4%E6%89%8B%E6%9C%AF%E6%9C%9F" target=_blank>有关围手术期更多指南</a></ul>, tagList=[TagDto(tagId=12269, tagName=心脏外科), TagDto(tagId=800, tagName=围手术期), TagDto(tagId=53152, tagName=连续性肾脏替代治疗)], categoryList=[CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6838, appHits=230, showAppHits=0, pcHits=4064, showPcHits=3256, likes=71, shares=11, comments=4, approvalStatus=1, publishedTime=Sat May 04 00:10:52 CST 2019, publishedTimeString=2019-01-29, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat May 04 00:10:52 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 00:39:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=心脏外科围手术期连续性肾脏替代治疗专家共识)])
心脏外科围手术期连续性肾脏替代治疗专家共识
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=966505, encodeId=e5c896650566, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b39b017ee66348258e0f6f76eaeb0cc7/932cc1ee7586406fb32ec82a576e3ef3.jpg, createdBy=633a5200535, createdName=1473a96dm28(暂无昵称), createdTime=Tue May 18 10:50:17 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958776, encodeId=e7e1958e7676, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55575481626, createdName=ms5000000243326290, createdTime=Tue Apr 20 15:57:04 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807592, encodeId=b6f280e5927a, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed Aug 12 06:12:39 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2021-05-18 1473a96dm28(暂无昵称)

    实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=966505, encodeId=e5c896650566, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b39b017ee66348258e0f6f76eaeb0cc7/932cc1ee7586406fb32ec82a576e3ef3.jpg, createdBy=633a5200535, createdName=1473a96dm28(暂无昵称), createdTime=Tue May 18 10:50:17 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958776, encodeId=e7e1958e7676, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55575481626, createdName=ms5000000243326290, createdTime=Tue Apr 20 15:57:04 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807592, encodeId=b6f280e5927a, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed Aug 12 06:12:39 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2021-04-20 ms5000000243326290

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=966505, encodeId=e5c896650566, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b39b017ee66348258e0f6f76eaeb0cc7/932cc1ee7586406fb32ec82a576e3ef3.jpg, createdBy=633a5200535, createdName=1473a96dm28(暂无昵称), createdTime=Tue May 18 10:50:17 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958776, encodeId=e7e1958e7676, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55575481626, createdName=ms5000000243326290, createdTime=Tue Apr 20 15:57:04 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807592, encodeId=b6f280e5927a, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed Aug 12 06:12:39 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-08-12 12582d2fm84暂无昵称

    不错

    0